Diagnosis & Disease Information

General Oncology

Perceived Burdens Predict Patients’ Withdrawal From Cancer Trials

By

Andrea S. Blevins Primeau, PhD, MBA

December 27, 2022

Cancer patients are more likely to withdraw from clinical trials if the perceived burdens of participation outweigh the perceived benefits.

Experts disagree about whether success in clinical trials translates to success in real world treatm

Chronic Myeloid Leukemia

Dasatinib: A Safe and Effective Option for Pediatric CML

By

James Nam, PharmD

March 5, 2018

Previous studies have shown that dasatinib may be an effective therapeutic alternative to imatinib.

Next post in Chronic Myeloid Leukemia

Researchers found that age and tumor size were the most significant factors for predicting renal cel

Pediatric CML: Imatinib Effective in the Front Line